PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients
about
A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics.Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.CNS cancer immunity cycle and strategies to target this for glioblastoma.Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis.
P2860
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
PI3 kinase mutations and mutat ...... ers in diffuse glioma patients
@ast
PI3 kinase mutations and mutat ...... ers in diffuse glioma patients
@en
type
label
PI3 kinase mutations and mutat ...... ers in diffuse glioma patients
@ast
PI3 kinase mutations and mutat ...... ers in diffuse glioma patients
@en
prefLabel
PI3 kinase mutations and mutat ...... ers in diffuse glioma patients
@ast
PI3 kinase mutations and mutat ...... ers in diffuse glioma patients
@en
P2093
P2860
P1476
PI3 kinase mutations and mutat ...... ers in diffuse glioma patients
@en
P2093
Kaspar Draaisma
Maarten M J Wijnenga
Marcel Smid
Pim J French
P2860
P2888
P356
10.1186/S40478-015-0265-4
P577
2015-12-23T00:00:00Z